Nanoparticles have attracted significant attention across diverse domains for their substantial contributions to drug delivery and targeting. They effectively minimize toxicity, enhance efficacy, and create novel avenues for pharmaceutical and drug delivery enterprises . Capping agents play a crucial role in functionalizing and stabilizing synthesized nanoparticles, serving as biologically acceptable reducing, stabilizing, or capping agents. These agents are carefully chosen to ensure compatibility with living systems . They play a pivotal role in shielding nanoparticles from agglomeration and enhancing reduction kinetics by forming complex structures with metallic ions in precursor salts .